Cotec Healthcare Prescribes Growth: IPO to Raise Rs 2.95 Billion, Pantomath Leads the Charge

In a move that signals its next phase of expansion, Cotec Healthcare has filed draft papers for its Initial Public Offering, aiming to raise up to Rs 2.95 billion through a fresh issue of shares. The IPO will be managed by Pantomath Capital Advisors, which has been appointed as the book-running lead manager. With a dual-track offering that includes both fresh equity and an offer for sale by existing shareholders, Cotec is positioning itself to fund capital expenditure and scale operations in India’s booming healthcare sector.

Here’s a comprehensive breakdown of the IPO structure, strategic intent, and market context.

Key highlights of the IPO filing

- Cotec Healthcare has filed its Draft Red Herring Prospectus with the Securities and Exchange Board of India  
- The IPO includes a fresh issue of shares worth up to Rs 2.95 billion  
- Existing shareholders will offload 6 million shares through an offer for sale  
- Pantomath Capital Advisors will serve as the book-running lead manager for the issue  
- The proceeds from the fresh issue will be used primarily to fund capital expenditure, including infrastructure upgrades and expansion of manufacturing capabilities  

Strategic use of proceeds

- Cotec plans to channel the IPO funds into capacity expansion, technology upgrades, and new product development  
- A portion of the proceeds will also be allocated toward working capital requirements and general corporate purposes  
- The company aims to strengthen its footprint in Tier 2 and Tier 3 cities, where demand for affordable healthcare solutions is rising rapidly  

Market positioning and growth outlook

- Cotec Healthcare operates in the pharmaceutical and medical devices segment, catering to both institutional and retail customers  
- The company has built a strong distribution network across India and is now eyeing deeper penetration into underserved markets  
- With rising healthcare awareness and government-led initiatives like Ayushman Bharat, the sector is poised for robust growth  
- Cotec’s IPO comes at a time when India’s healthcare market is projected to reach USD 372 billion by 2027, growing at a CAGR of 22 percent  

Investor sentiment and IPO climate

- India’s IPO market is experiencing a record-breaking year, with fundraising expected to cross Rs 2 trillion in 2025  
- Healthcare, along with consumer tech and manufacturing, is among the top-performing sectors in IPO activity  
- Pantomath Capital, known for its mid-market expertise, has played a key role in driving investor interest in emerging healthcare brands  
- The IPO is expected to attract both institutional and retail investors looking for exposure to India’s expanding healthcare ecosystem  

Offer for sale: shareholder dynamics

- The offer for sale component allows existing shareholders to partially exit, providing liquidity while retaining long-term strategic interest  
- The identities of the selling shareholders have not been disclosed in the draft papers, but the move suggests confidence in the company’s valuation and future prospects  

Why this matters

- Cotec Healthcare’s IPO is more than a capital raise—it’s a signal of sectoral momentum and investor appetite for healthcare innovation  
- The dual structure of fresh issue and offer for sale balances growth funding with shareholder liquidity  
- With Pantomath Capital steering the offering, the IPO is expected to be well-received in India’s buoyant equity markets  
- As healthcare becomes a national priority, companies like Cotec are well-positioned to deliver both impact and investor returns  

Sources: Reuters, Business Standard, Economic Times, SMEStreet